Skip to main content

Search

Clear
Filter by Type
Filter by Topics
Filter by Symptoms & Conditions
Filter by Year
From PTJ: Common Activity Trackers May Be Inaccurate for Patients With PD

Aug 6, 2018/Review

Research suggests that PTs may want to think twice about the data they get from patients' commercial activity trackers.

Photo Collection: A Look at APTA's Centennial Celebration

Sep 28, 2021/Roundup

We honored our past, thought about our future, and had some good times along the way.

Is Your Practice ADA Compliant? Part 3 of a 3-Part Series

Jul 24, 2023/Article

Communicating with an individual with a communications disability

IMPROVE VTE Risk Model

Oct 31, 2021/Test & Measure

The IMPROVE VTE Risk Model is an assessment tool that is used to discriminate risk of developing validated venous thromboembolism (VTE) in patients who are critically ill, based on clinical variables.1

Keeping Pain Out of the Red Zone

Jul 1, 2017/Feature

The mechanisms of pain are both physical and psychological. Here's what PTs and PTAs need to know in order to gauge treatment strategies.

Innovations in Telehealth

Apr 1, 2017/Feature

As telehealth moves from theory to practice, here's an update.

Medicare Payment Changes: 2021

Jan 15, 2021/Resource

2021 brings numerous changes to Medicare regulation related to telehealth, the Physician Fee Schedule payment, NCCI edits, and the Quality Payment Program.

You Down With QPP? Watch and See (And Take the Quiz)

Aug 9, 2017/News

Since late 2015, APTA has been rolling out new resources to help members prepare for what's coming down the pike as CMS implements its Quality Payment Program (QPP).

Researchers: Studies Show Telehealth to Be 'Feasible and Effective' in Rehab

Sep 19, 2022/Review

A systematic review involving more than 200,000 patients with a variety of conditions revealed consistently positive results for telerehab.

Coronavirus Update: December 7

Dec 7, 2022/Roundup

APTA's message on long COVID, physical activity and vaccination effectiveness, long COVID costs, and more.